Majuven

What is Majuven?

Majuven is a venture capital firm based in Singapore that provides funding to early and growth-stage companies. With a focus on sectors such as biomedical sciences, services, and sustainable technology, Majuven supports bright ideas and strong teams capable of bringing these ideas to market.

The firm's investment ranges from a minimum of 1.5 million to a maximum of 40 million, targeting businesses in the energy, food & beverage, material science, and medical devices industries. Majuven is particularly known for encouraging disruptive and evolving trends in high-tech segments of healthcare, financial services, and digital consumerism, and typically supports companies from the Seed stage up to Series B rounds.

Companies benefit from Majuven not only in terms of financial capital but also by gaining access to a powerful network of influential contacts across Asia, essential for their regionalization plans. The network derives from the founding partners' distinguished corporate experience, spanning long tenured careers, leveraging it actively to benefit their portfolio.

Majuven's investments are guided by leadership with profound expertise in the industry and successful track records in business development. This includes Mr. Lim Ho Kee with vast experience in various executive roles, Prof.

Low Teck Seng holding a prestigious placement as CEO at the National Research Foundation, and Mr. Lu Yoh Chie, who brings over 30 years of experience in the medical industry.

Majuven is also committed to providing domain expertise, trusting their entrepreneurs to their advice on strategy, operations, marketing, deal-making, and capital raising. Their approach ensures not just investments but also a significant contribution to building up the businesses they invest in.